ADVANCING KNOWLEDGE OF ATHEROSCLEROSIS TREATMENT OPTIONS: CLINICAL IMPLICATIONS FOR PATIENTS (SB-109)

Friday, October 27, 2023

12:00 – 12:20 EST

Location: Palais, 220CDE - Theatre 2

Presenter(s)

Subodh Verma, MD, PhD (he/him/his)

Cardiac Surgeon
CSCS
University of Toronto
Preston Mason, PhD

Professor
Brigham and Women's Hospital, Harvard Medical School
Brigham and Women's Hospital, Harvard Medical School
Eva Lonn, MD, MSc, FRCPC, FACC (she/her/hers)

Senior Scientist; Medical Director
Population Health Research Institute; Heart Failure Program & Cardiac Health and Rehabilitation Program (Hamilton Health Sciences)
McMaster University

Disclosure(s):

Subodh Verma, MD, PhD: Amarin: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing); Amgen: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); AstraZeneca: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing); Bayer: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing); Boehringer-Ingelheim: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing); Canadian Medical and Surgical Knowledge Translation Research Group: Speaker/Honoraria (Ongoing); Eli Lilly: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing); HLS Therapeutics: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing); Janssen: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Novartis: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Novo Nordisk: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing); Pfizer: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing); PhaseBio: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Terminated, February 17, 2023), Speaker/Honoraria (Terminated, February 17, 2023); S&L Solutions: Speaker/Honoraria (Ongoing); Sanofi: Speaker/Honoraria (Ongoing)

Sidebar Sessions are sponsored learning activities and are not part of the 2023 Vascular accredited program developed by the Scientific Planning Committee and do not qualify for Maintenance of Certification Section 1 credits.